Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Alternative Non-cross-resistant Adjuvant Chemotherapy for Operable Breast Cancer Non-response to Primary Chemotherapy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01019616
Recruitment Status : Unknown
Verified January 2019 by Tao OUYANG, Peking University.
Recruitment status was:  Active, not recruiting
First Posted : November 25, 2009
Last Update Posted : January 18, 2019
Sponsor:
Collaborators:
Beijing Municipal Science & Technology Commission
Peking Union Medical College Hospital
Chinese Academy of Medical Sciences
Peking University First Hospital
Peking University People's Hospital
Beijing Chao Yang Hospital
307 Hospital of PLA
Information provided by (Responsible Party):
Tao OUYANG, Peking University

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Unknown
Estimated Primary Completion Date : December 31, 2019
Estimated Study Completion Date : December 31, 2019